Quantification of impairment in MS: discussion of the scales in use

Abstract

Accurate, efficient measurement of disease status has become a key issue in MS clinical practice and research. Despite some perceived problems, the Expanded Disability Status Scale (EDSS) remains the most widely used comprehensive measure of impairment. There is also a place for more restricted scales of impairment which focus on some aspects of neurological function in more detail than the EDSS e.g. measures of ambulation, arm function and cognitive function. Improvements in scales of impairment in the future is likely to result from the use of more quantitative tests of selected components of the neurological examination.

Keywords

EDSS impairment scales multiple sclerosis

Get full access to this article

View all access options for this article.

References

World Health Organisation . (1980) International Classification of Impairment. World Health Organisation. Geneva .

Kurtzke JF. (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

Willoughby EW , Paty DW. (1988) Scales for rating impairment in multiple sclerosis: a critique . Neurology 38: 1793-1798 .

Weinshenker BG et al. (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability . Brain 112: 133-146 .

Weinshenker BG , Issa M , Baskerville J. (1996) Meta-analysis of the placebo-treated groups in clinical trials of progressive multiple sclerosis . Neurology 46: 1613-1619 .

Amato MP et al. (1988) Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis . Arch Neurol 45: 746-748 .

Noseworthy JH et al. (1990) Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial . Neurology 40: 971-975 .

Francis DA , Bain P , Swan AV , Hughes RAC. (1991) An assessment of disability rating scales used in multiple sclerosis . Arch Neurol 48: 299-301 .

Goodkin DE et al. (1992) Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke expanded disability status scale (EDSS). Multiple Sclerosis Collaborative Research Group . Neurology 42: 859-863 .

10.

Amato MP et al. (1987) Inter- and intra-observer reliability in the employment of Kurtzke scoring system in multiple sclerosis . Ital J Neurol Sci 3(Suppl 6): 129-131 .

11.

Mickey MR , Ellison GW , Myers LW. (1984) An illness severity score for multiple sclerosis . Neurology 34: 1343-1347 .

12.

Confavreux C et al. (1992) EDMUS, a European database for multiple sclerosis . J Neurol Neurosurg Psychiat 55: 671-676 .

13.

Lechner-Scott J , Brunnschweiler H , Kappos L. (1995) The Study Steering Committee. Is it possible to achieve cross-cultural European agreement in the assessment of neurological deficits? First experience in the European interferon beta-1b trial for secondary progressive MS . J Neuroimmunol 42 (Suppl 1).

14.

Sipe JC et al. (1989) A neurological rating scale (NRS) for use in multiple sclerosis . Neurology 34: 1368-1372 .

15.

Hauser SL et al. (1983) Intensive immunosuppression in progressive multiple sclerosis . N Engl J Med 308: 173-178 .

16.

Potvin AR , Tourtellotte WW. (1975) The neurological examination: advancements in its quantification . Arch Phys Med Rehabil 56: 425-437 .

17.

Goodkin DE et al. (1995) Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis . Ann Neurol 37: 30-40 .